Mini Review

The Association of Cognitive Function and Cerebrovascular Health with the Risk of Future Cardiovascular Events and Mortality: A Mini-Review

Somayeh Rostamian*

Imperial College Translational and Experimental Medicine Building, Imperial College London, England, United Kingdom.

Received Date: 12/10/2021;   Published Date: 03/12/2021

*Corresponding author: Somayeh Rostamian, Ph.D., Imperial College London, Imperial College Translational and Experimental Medicine Building, Du Cane Road, W12 0NN, London, United Kingdom

DOI: 10.46998/IJCMCR.2021.15.000369

Human lifespans are prolonged today than in the immediate past around the world. Overall, life expectancy has been gradually increasing for many years and has more than doubled in the past two centuries [1]. The growing elderly populations are associated with several challenges of the medical and economic policies due to the increased number of care-needed dependent older people limited by age-associated cognitive impairment [2]. The human brain deteriorates with age; however, the rate and the paths of declines among the brain regions and between individuals are not indistinguishable [3]. Age-associated cognitive decline is a relevant experience that happens over the lifespan. However, there are considerable heterogeneities among elderly populations both inter-and intra-individually [4,5]. Changes in brain structure are dependent on many factors but are mostly related to age, sex, and vascular health [6].

Vascular health is a significant factor associated with cognitive brain ageing and cardiovascular events. Several studies have shown that a decline in vascular health has substantial impacts on the brain health [7]. Although the brain comprises only about 2% of body mass, it receives nearly 20% of total cardiac output. Cerebral microcirculation is responsible for delivering oxygen and nutrients needed for metabolism and the deterge of toxic products. Therefore, cerebral microcirculation is essential in preserving brain health and is associated with normal and pathological cognitive brain ageing in terms of age-related structural and functional brain abnormalities [8]. Vascular risk factors, including hypertension, hyperlipidemia, obesity, smoking, and diabetes mellitus, are all independently associated with structural brain abnormalities before the clinical manifestation of cardiovascular or cerebrovascular diseases [9]. Moreover, regardless of their roles in overt vascular events, vascular risk factors are related to pathological brain changes and accelerate the risk of cognitive impairment, dementia, and mortality [10-12].

In addition, research has demonstrated that poor cognitive function and dementia prior to the onset of cerebrovascular accidents and cardiovascular events are associated with a greater risk of such events [13,14]. The lower cognitive function might reflect the previous exposure to cardiovascular risk factors and substantial covert vascular damages that can predispose a person to clinically recognized cardiovascular events in the future. Therefore, poor cognitive function performance might be considered as an early manifestation of clinically unrecognized cerebral and systemic vascular pathologies, which signals the future risk of cardiovascular events and mortality [15].

Neuroimaging studies have shown that existing structural brain abnormalities, including infarcts, microbleeds, white matter hyperintensities, and low cerebral blood flow, are robustly related to worse cognitive performance [16-18]. Additionally, it has been presented that impaired brain structural integrity and insufficient cerebral blood flow are associated with a greater risk of cardiovascular and non-cardiovascular mortality in older adults [19,20]. Thus, brain lesions and impaired cerebrovascular hemodynamics have been proposed as major mechanisms behind the link between cognitive impairment and mortality. Briefly, cognitive impairment and abnormalities in brain structures reflect the lack of brain integrity and may put elderly individuals at an increased risk of mortality [21]. Moreover, findings from several studies have indicated that certain domains of cognition might be more vulnerable to the adverse effects of cardiovascular risk factors [22]. Impaired executive function and attention is a major clinical presentation in patients with vascular cognitive impairment, whereas memory deficit is mainly associated with Alzheimer's type of dementia [23,24].

The association between cognitive function and the risk of vascular injuries can be explained in different ways. Cardiovascular risk factors such as obesity, smoking, hypertension, diabetes mellitus, and arterial fibrillation are associated with both cognitive impairment and cardiovascular diseases [25-28]. Besides, lower socioeconomic status and risky lifestyle behaviors, such as lower educational attainment, unhealthy diet, sedentary behavior, and pattern of alcohol intake, which indirectly increase the risk of coronary heart disease and stroke, could be considered as risk factors for cognitive impairment [29-31]. Health literacy is the other prominent possible mechanism underlying this association. People with poor health literacy are less likely to seek preventive strategies before the onset of diseases, have less ability to recognize the symptom of the disease, and less tendency to stick to the treatment procedure [32,33]. Moreover, such risk factors affect the brain's neural plasticity and integrity, which are needed for optimal brain and body functioning [34]. Study findings have suggested that evaluating different domains of cognitive function may identify participants at higher risk of cardiovascular diseases, and it can be used, alone or in combination with other predictors, to detect individuals at increased risk of vascular events and improve the prevention strategies [35].

References

  1. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002; 296: 1029-1031.
  2. Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment-a review of the evidence and causal mechanisms. Ageing research reviews. 2013; 12: 840-851.
  3. Raz N, Ghisletta P, Rodrigue KM, Kennedy KM, Lindenberger U. Trajectories of brain aging in middle- aged and older adults: regional and individual differences. Neuroimage. 2010; 51: 501-511.
  4. Christensen H. What cognitive changes can be expected with normal ageing? The Australian and New Zealand journal of psychiatry. 2001; 35: 768-775.
  5. Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, et al. Age- associated cognitive decline. British medical bulletin, 2009; 92: 135-152.
  6. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex. 2005; 15: 1676-1689.
  7. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, et al. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Annals of neurology. 2017; 82: 706-718.
  8. Deak F, Freeman WM, Ungvari Z, Csiszar A, Sonntag WE. Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment. J Gerontol a Biol Sci Med Sci. 2016; 71: 13-20.
  9. Friedman JI, Tang CY, de Haas HJ, Changchien L, Goliasch G, Dabas P, et al. Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients. JACC Cardiovasc Imaging. 2014; 7: 1039-1053.
  10. Carotenuto A, Rea R, Colucci L, Ziello AR, Molino I, Carpi S, et al. Late and early onset dementia: what is the role of vascular factors? A retrospective study. J Neurol Sci. 2012; 322: 170-175.
  11. Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013; 33: 1696-1706.
  12. Whiteley W, Gupta A, Thomas Godec T, Rostamian S, Andrew Whitehouse A, Mackay J, et al. Long- term incidence of stroke and dementia in ASCOT. Stroke, 2021; 52(10): 3088-3096.
  13. O'Donnell M, Teo K, Gao P, Anderson C, Sleight P, Dans A, et al. Cognitive impairment and risk of cardiovascular events and mortality. European heart journal. 2012; 33: 1777-1786.
  14. Rostamian S, Mahinrad S, Stijnen T, Sabayan B, de Craen AJ. Cognitive impairment and risk of stroke: a systematic review and meta-analysis of prospective cohort studies. Stroke. 2014; 45: 1342-1348.
  15. Rostamian S, de Haan S, van der Grond J, van Buchem MA, Ford I, Jukema JW, et al. Cognitive Function   in   Dementia-Free   Subjects   and   Survival    in    Old    Age:    The    PROSPER    Study.    Am J Med. 2019; 132(12): 1466-1474.
  16. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. The New England journal of medicine. 2003; 348: 1215-1222.
  17. Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain: a journal of neurology, 2004; 127: 2265-2275.
  18. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Archives of neurology, 2008; 65: 94-100.
  19. Altmann-Schneider I, Trompet S, de Craen AJ, van Es AC, Jukema JW, Stott DJ, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke. 2011; 42: 638-644.
  20. Sabayan B, van der Grond J, Westendorp RG, Jukema JW, Ford I, Buckley BM, et al. Total cerebral blood flow and mortality in old age: a 12-year follow-up study. Neurology. 2013; 81: 1922-1929.
  21. Deary IJ. Looking for 'system integrity' in cognitive epidemiology. Gerontology, 2012; 58: 545-553.
  22. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003; 2: 89-98.
  23. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke, 2011; 42: 2672-2713.
  24. Rostamian S, van Buchem MA, Westendorp RG, Jukema JW, Mooijaart SP, Sabayan B, et al. Executive function, but not memory, associates with incident coronary heart disease and stroke. Neurology, 2015; 85: 783-789.
  25. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and latelife as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011;12: e426-e437.
  26. Cervilla JA, Prince M, Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community-based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry. 2000; 68: 622-626.
  27. Farr SA, Yamada KA, Butterfield DA, Abdul HM, Xu L, Miller NE, Banks WA and Morley JE. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology, 2008; 149: 2628-2636.
  28. Knecht S, Oelschlager C, Duning T, Lohmann H, Albers J, Stehling C, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. European heart journal, 2008; 29: 2125-2132.
  29. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA, 2002; 288: 2709-2716.
  30. Wee LE, Yeo WX, Yang GR, Hannan N, Lim K, Chua C, et al. Individual and Area Level Socioeconomic Status and Its Association with Cognitive Function and Cognitive Impairment (Low MMSE) among Community-Dwelling Elderly in Singapore. Dement Geriatr Cogn Dis Extra, 2012; 2: 529-542.
  31. Stringhini S, Carmeli C, Jokela M, Avendano M, Muennig P, Guida F, et al. Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women. Lancet, 2017; 389: 1229-1237.
  32. Federman AD, Sano M, Wolf MS, Siu AL, Halm EA. Health literacy and cognitive performance in older adults. Journal of the American Geriatrics Society. 2009; 57: 1475-1480.
  33. Dharmapuri S, Best D, Kind T, Silber TJ, Simpson P, D'Angelo L. Health literacy and medication adherence in adolescents. The Journal of paediatrics, 2015; 166: 378-382.
  34. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nature reviews Neuroscience, 2006; 7: 30-40.
  35. Rostamian S, van Buchem MA, Jukema JW, Gussekloo J, Poortvliet R, de Craen AJ, et al. Lower Performance in Orientation to Time and Place Associates with Greater Risk of Cardiovascular Events and Mortality in the Oldest Old: Leiden 85-Plus Study. Front Aging Neurosci. 2017; 27(9): 307.
logo

Subscribe to newsletter

© 2020. All rights reserved.

TOP